Ross MacDonald
Corporate Officer/Principal bij Licensing Executives Society of Australia & New Zealand
Vermogen: 247 920 $ op 31-03-2024
Actieve functies van Ross MacDonald
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Licensing Executives Society of Australia & New Zealand | Corporate Officer/Principal | - | - |
Uniseed Management Pty Ltd.
 Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Private Equity Investor | - | - |
Loopbaan van Ross MacDonald
Eerdere bekende functies van Ross MacDonald
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Director/Board Member | 01-08-2013 | 01-07-2023 |
| Chief Executive Officer | 01-08-2013 | 01-07-2023 | |
| Director of Finance/CFO | 01-08-2013 | - | |
| RESPIRI LIMITED | Director/Board Member | 03-04-2012 | 05-02-2014 |
| Independent Dir/Board Member | 03-04-2012 | 05-02-2014 | |
| TELESSO TECHNOLOGIES LTD. | Director/Board Member | 01-02-2003 | 19-11-2013 |
| ALGORAE PHARMACEUTICALS LIMITED | Director/Board Member | 07-12-2010 | 24-06-2011 |
| Chief Executive Officer | 02-08-2010 | 24-06-2011 | |
| Corporate Officer/Principal | 03-08-2010 | 07-12-2010 | |
Relevare Pharmaceuticals Ltd.
 Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Director/Board Member | - | - |
Stiefel Laboratories, Inc. (New York)
 Stiefel Laboratories, Inc. (New York) Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. (New York) develops, manufactures and markets products for the care and treatment of skin diseases. The company is headquartered in Oak Hill, NY. | Corporate Officer/Principal | 01-01-2006 | - |
Stiefel Research Australia Pty Ltd.
 Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The private company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | President | - | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░ ░░░░░░░░ ░ ░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van Ross MacDonald
| Monash University | Doctorate Degree |
Statistieken
Internationaal
| Australië | 11 |
| Verenigde Staten | 3 |
| Nieuw-Zeeland | 2 |
Operationeel
| Director/Board Member | 6 |
| Corporate Officer/Principal | 5 |
| Chief Executive Officer | 3 |
Sectoraal
| Health Technology | 12 |
| Consumer Services | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
| RESPIRI LIMITED | Health Technology |
| CYNATA THERAPEUTICS LIMITED | Health Technology |
| Bedrijven in privébezit | 10 |
|---|---|
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Telesso Technologies Ltd.
 Telesso Technologies Ltd. Pharmaceuticals: OtherHealth Technology Telesso Technologies Ltd. was engaged in biotechnology research and development. The company was founded on December 15, 1995 and was headquartered in Melbourne, Australia. | Health Technology |
| FH Faulding & Co. Ltd. | Health Technology |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The private company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Health Technology |
Uniseed Management Pty Ltd.
Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Finance |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Health Technology |
Stiefel Laboratories, Inc. (New York)
Stiefel Laboratories, Inc. (New York) Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. (New York) develops, manufactures and markets products for the care and treatment of skin diseases. The company is headquartered in Oak Hill, NY. | Health Technology |
Sinclair Pharmaceuticals Ltd.
 Sinclair Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1971, Sinclair Pharmaceuticals Ltd. is a subsidiary of Huadong Medicine Co., Ltd. that manufactures and distributes pharmaceutical products. The private company is based in Chester, UK. | Health Technology |
| Licensing Executives Society of Australia & New Zealand | |
Relevare Pharmaceuticals Ltd.
Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Health Technology |
- Beurs
- Insiders
- Ross MacDonald
- Ervaring
